Table 5.
Endpoints/adverse events by quartiles of LA:DGLA.
| Total Pat. No. | LA:DGLA Quartile 1 | LA:DGLA Quartile 2 | LA:DGLA Quartile 3 | LA:DGLA Quartile 4 | p-Value for Trend |
|---|---|---|---|---|---|
| n = 1002 | n = 251 | n = 250 | n = 251 | n = 250 | |
| MACE | 42 (16.7%) | 50 (20.0%) | 58 (23.1%) | 58 (23.2%) | 0.049 |
| AMI | 20 (8.0%) | 21 (8.4%) | 21 (8.4%) | 16 (6.4%) | 0.53 |
| Revasc. | 16 (6.4%) | 20 (8.0%) | 26 (10.4%) | 15 (6.0%) | 0.87 |
| Stroke | 6 (2.4%) | 5 (2.0%) | 8 (3.2%) | 13 (5.2%) | 0.05 |
| Heart failure | 9 (3.6%) | 10 (4.0%) | 14 (5.6%) | 12 (4.8%) | 0.37 |
| Total death | 10 (4.0%) | 14 (5.6%) | 11 (4.4%) | 20 (8.0%) | 0.09 |
LA = linoleic acid. MACE = Major Adverse Clinical Events (nonfatal MI, unscheduled coronary revascularization, stroke, all-cause death or hospitalization for new or worsened heart failure). AMI = Acute Myocardial Infarction. Revasc. = Revascularization (percutaneous coronary intervention or coronary artery bypass grafting). HF = Heart Failure. p-values for trends across the quartiles.